106840-37-3 Usage
General Description
Ethyl 2-(acetylamino)-1,3-thiazole-5-carboxylate and 2-Acetamido-5-(ethoxycarbonyl)-1,3-thiazole are both organic compounds with similar chemical structures. Both chemicals contain a thiazole ring, which is a five-membered heterocyclic ring containing one sulfur and one nitrogen atom. The presence of an acetylamino group in both compounds suggests potential pharmaceutical and medicinal applications. The ethyl and ethoxycarbonyl groups in these chemicals indicate that they may have similar properties and potential uses as ester compounds. These chemicals may be used in the synthesis of pharmaceutical compounds or as reagents in organic chemistry reactions.
Check Digit Verification of cas no
The CAS Registry Mumber 106840-37-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,6,8,4 and 0 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 106840-37:
(8*1)+(7*0)+(6*6)+(5*8)+(4*4)+(3*0)+(2*3)+(1*7)=113
113 % 10 = 3
So 106840-37-3 is a valid CAS Registry Number.
InChI:InChI=1/C8H10N2O3S/c1-3-13-7(12)6-4-9-8(14-6)10-5(2)11/h4H,3H2,1-2H3,(H,9,10,11)
106840-37-3Relevant articles and documents
SPIRO COMPOUNDS AS GLYCOSIDASE INHIBITORS
-
Page/Page column 149, (2020/03/15)
Compounds of formula (I) wherein A, R, L, Z, Q1, Q2 and n have the meaning according to the claims can be employed, inter alia, for the treatment of tauopathies and Alzheimer's disease.
FUSED GLYCOSIDASE INHIBITORS
-
Page/Page column 125, (2020/09/08)
Compounds of formula (I), wherein A, Z, E, R1, R2, m and n have the meaning according to the claims can be employed, inter alia, for the treatment of tauopathies and Alzheimer's disease.
GLYCOSIDASE INHIBITORS
-
Page/Page column 85; 86, (2014/10/15)
Compounds of formula (I) wherein X1, X2, W, R1 to R5, L and m have the meaning according to the claims, are glucosidase inhibitors, and can be employed, inter alia, for the treatment of Alzheimer's disease.
